BlackRock Institutional Trust’s Sage Therapeutics SAGE Stock Holding History

BlackRock Institutional Trust’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$39.9M	Buy	782,105 +100,513	+15%	+$4.74M	0.01%	1486
2016 Q3	$31.4M	Buy	681,592 +190,065	+39%	+$7.74M	﹤0.01%	1581
2016 Q2	$14.8M	Buy	491,527 +95,861	+24%	+$3.2M	﹤0.01%	2046
2016 Q1	$12.7M	Buy	395,666 +118,153	+43%	+$4.16M	﹤0.01%	2120
2015 Q4	$16.2M	Sell	277,513 -3,124	-1%	-$155K	﹤0.01%	2006
2015 Q3	$11.9M	Buy	280,637 +68,775	+32%	+$4.24M	﹤0.01%	2168
2015 Q2	$15.5M	Buy	211,862 +139,279	+192%	+$8.95M	﹤0.01%	2097
2015 Q1	$3.65M	Buy	72,583 +17,380	+31%	+$747K	﹤0.01%	2862
2014 Q4	$2.02M	Buy	55,203 +1,559	+3%	+$58.1K	﹤0.01%	3097
2014 Q3	$1.69M	Buy	+53,644	New	+$1.55M	﹤0.01%	3150

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock Institutional Trust's SAGE Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Sage Therapeutics (SAGE) stake by 15% in Q4 2016, buying an estimated $4.74M and bringing the position to 782,105 shares worth $39.9M. The position accounts for 0.01% of the portfolio, ranked #1486.

BlackRock Institutional Trust first reported a position in SAGE in Q3 2014 and has held it in 10 quarters since. 165 funds tracked by Wall St. Rank hold SAGE as of Q4 2016.

BlackRock Institutional Trust held 782,105 shares of Sage Therapeutics worth $39.9M as of Q4 2016.
BlackRock Institutional Trust bought 100,513 Sage Therapeutics shares in Q4 2016, an estimated $4.74M.
Sage Therapeutics made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1486 holding.
BlackRock Institutional Trust first reported a position in Sage Therapeutics in Q3 2014 and has held it in 10 quarters since.
165 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.